MedTrace Logo

Pharmacokinetics of VVN461 Ophthalmic Solution

NCT06906198 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2025-04-02

No results posted yet for this study

Summary

This is a single-center, double-masked, randomized, vehicle-controlled study conducted in China in adult healthy subjects

Conditions

  • Healthy Volunteers

Interventions

DRUG

VVN461 Ophthalmic Solution 1.0%

VVN461, 1.0%

DRUG

VVN461 Ophthalmic Solution 0.5%

VVN461, 0.5%

DRUG

VVN461 Ophthalmic Solution 0.25%

VVN461, 0.25%

DRUG

VVN461 Ophthalmic Solution Placebo

Vehicle

Sponsors & Collaborators

  • VivaVision Biotech, Inc

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-01
Primary Completion
2023-05-10
Completion
2023-12-22

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06906198 on ClinicalTrials.gov